These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 577635)

  • 1. Preparation of factor IX concentrate from platelet-rich plasma.
    Smith JK; Snape TJ; Bidwell E
    Thromb Haemost; 1977 Apr; 37(2):363-6. PubMed ID: 577635
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of a proposed international standard for blood coagulation factor IX.
    Brozović M; Kirkwood TB; Robertson I
    Thromb Haemost; 1976 Feb; 35(1):222-36. PubMed ID: 989189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and clinical use of a new factor IX concentrate].
    Lopaciuk S; Poszwiński P
    Acta Haematol Pol; 1978; 9(2):107-12. PubMed ID: 665130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of human factor IX by chromatography of a coagulation factor concentrate.
    Suomela H
    Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets contain releasable coagulation factor IX antigen.
    Romp KG; Monroe DM; Hoffman M
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):905-10. PubMed ID: 8148483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
    Weibrich G; Kleis WK; Hitzler WE; Hafner G
    Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets contain releasable coagulation factor IX antigen: response.
    Hoffman M; Romp K; Monroe D
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):657-8. PubMed ID: 7841326
    [No Abstract]   [Full Text] [Related]  

  • 8. [A factor IX-concentrate for the treatment of haemophilia B].
    Suomela H; Myllylä G
    Duodecim; 1971; 87(1):31-8. PubMed ID: 5539580
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence or absence of factor IX in normal platelets.
    Fabris F; Betterle C; Girolami A
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):659. PubMed ID: 7841327
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary in vivo evaluation of a nanofiltered factor IX concentrate.
    Mannucci PM; Tradati F
    Thromb Haemost; 1995 Apr; 73(4):737-8. PubMed ID: 7495096
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems.
    Leitner GC; Gruber R; Neumüller J; Wagner A; Kloimstein P; Höcker P; Körmöczi GF; Buchta C
    Vox Sang; 2006 Aug; 91(2):135-9. PubMed ID: 16907874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y; Boyeldieu D; Stieltjes N
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor IX.
    White GC; Beebe A; Nielsen B
    Thromb Haemost; 1997 Jul; 78(1):261-5. PubMed ID: 9198163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and heat-treatment of factor-IX-concentrates.
    Stampe D; Wieland B; Köhle A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):523-7. PubMed ID: 2465966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
    Uszyński L; Poszwiński P
    Acta Haematol Pol; 1971; 2(2):109-14. PubMed ID: 5170671
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
    Haanen C; McShine RL; Kunst A
    Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
    [No Abstract]   [Full Text] [Related]  

  • 18. A quantitative two-stage assay for factor IX (Christmas factor) using plasma from dogs with Christmas disease.
    Aronson DL; Dodds WJ; Mustafa AJ
    Thromb Diath Haemorrh; 1972 Jul; 27(3):529-34. PubMed ID: 4662614
    [No Abstract]   [Full Text] [Related]  

  • 19. [The preparation of platelet-rich plasma for platelet counts and tests of platelet function (author's transl)].
    Schulz V; Kochsiek K; Köstering H; Walther Ch
    Z Klin Chem Klin Biochem; 1971 Jul; 9(4):324-8. PubMed ID: 4951027
    [No Abstract]   [Full Text] [Related]  

  • 20. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
    Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
    Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.